nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Skin exfoliation—Doxorubicin—lung cancer	0.00101	0.0013	CcSEcCtD
Phenylephrine—Immune system disorder—Cisplatin—lung cancer	0.00101	0.0013	CcSEcCtD
Phenylephrine—Mediastinal disorder—Cisplatin—lung cancer	0.00101	0.0013	CcSEcCtD
Phenylephrine—Arrhythmia—Cisplatin—lung cancer	0.000998	0.00129	CcSEcCtD
Phenylephrine—Nausea—Teniposide—lung cancer	0.000993	0.00128	CcSEcCtD
Phenylephrine—Urticaria—Topotecan—lung cancer	0.000984	0.00127	CcSEcCtD
Phenylephrine—Visual impairment—Paclitaxel—lung cancer	0.000967	0.00125	CcSEcCtD
Phenylephrine—Syncope—Irinotecan—lung cancer	0.00096	0.00124	CcSEcCtD
Phenylephrine—Paraesthesia—Vinorelbine—lung cancer	0.000952	0.00123	CcSEcCtD
Phenylephrine—Cardiac disorder—Etoposide—lung cancer	0.00095	0.00123	CcSEcCtD
Phenylephrine—Dyspnoea—Vinorelbine—lung cancer	0.000945	0.00122	CcSEcCtD
Phenylephrine—Loss of consciousness—Irinotecan—lung cancer	0.000941	0.00122	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—lung cancer	0.000941	0.00122	CcSEcCtD
Phenylephrine—Hypersensitivity—Vinblastine—lung cancer	0.00094	0.00121	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—lung cancer	0.000935	0.00121	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Docetaxel—lung cancer	0.000934	0.00121	CcSEcCtD
Phenylephrine—Cardiac disorder—Paclitaxel—lung cancer	0.000931	0.0012	CcSEcCtD
Phenylephrine—Myocardial infarction—Docetaxel—lung cancer	0.000929	0.0012	CcSEcCtD
Phenylephrine—Angiopathy—Etoposide—lung cancer	0.000928	0.0012	CcSEcCtD
Phenylephrine—Hypertension—Irinotecan—lung cancer	0.000925	0.00119	CcSEcCtD
Phenylephrine—Immune system disorder—Etoposide—lung cancer	0.000924	0.00119	CcSEcCtD
Phenylephrine—Mediastinal disorder—Etoposide—lung cancer	0.000922	0.00119	CcSEcCtD
Phenylephrine—Vision blurred—Cisplatin—lung cancer	0.000916	0.00118	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000915	0.00118	CcSEcCtD
Phenylephrine—Hypersensitivity—Topotecan—lung cancer	0.000913	0.00118	CcSEcCtD
Phenylephrine—Tremor—Cisplatin—lung cancer	0.000911	0.00118	CcSEcCtD
Phenylephrine—Angiopathy—Paclitaxel—lung cancer	0.00091	0.00118	CcSEcCtD
Phenylephrine—Pain—Vinorelbine—lung cancer	0.000906	0.00117	CcSEcCtD
Phenylephrine—Immune system disorder—Paclitaxel—lung cancer	0.000906	0.00117	CcSEcCtD
Phenylephrine—Mediastinal disorder—Paclitaxel—lung cancer	0.000904	0.00117	CcSEcCtD
Phenylephrine—Hypertension—Gemcitabine—lung cancer	0.000901	0.00116	CcSEcCtD
Phenylephrine—Arrhythmia—Paclitaxel—lung cancer	0.000896	0.00116	CcSEcCtD
Phenylephrine—Chest pain—Gemcitabine—lung cancer	0.000888	0.00115	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000882	0.00114	CcSEcCtD
Phenylephrine—Mental disorder—Paclitaxel—lung cancer	0.000879	0.00114	CcSEcCtD
Phenylephrine—Pruritus—Topotecan—lung cancer	0.000876	0.00113	CcSEcCtD
Phenylephrine—Dysgeusia—Etoposide—lung cancer	0.000872	0.00113	CcSEcCtD
Phenylephrine—Pruritus—Erlotinib—lung cancer	0.000867	0.00112	CcSEcCtD
Phenylephrine—Shock—Irinotecan—lung cancer	0.00086	0.00111	CcSEcCtD
Phenylephrine—Nervous system disorder—Irinotecan—lung cancer	0.000857	0.00111	CcSEcCtD
Phenylephrine—Tension—Paclitaxel—lung cancer	0.000857	0.00111	CcSEcCtD
Phenylephrine—Dysgeusia—Paclitaxel—lung cancer	0.000855	0.00111	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—lung cancer	0.00085	0.0011	CcSEcCtD
Phenylephrine—Nervousness—Paclitaxel—lung cancer	0.000848	0.0011	CcSEcCtD
Phenylephrine—Hyperhidrosis—Irinotecan—lung cancer	0.000845	0.00109	CcSEcCtD
Phenylephrine—Dizziness—Vinblastine—lung cancer	0.000843	0.00109	CcSEcCtD
Phenylephrine—Urticaria—Vinorelbine—lung cancer	0.000842	0.00109	CcSEcCtD
Phenylephrine—Nervous system disorder—Gemcitabine—lung cancer	0.000835	0.00108	CcSEcCtD
Phenylephrine—Skin disorder—Gemcitabine—lung cancer	0.000827	0.00107	CcSEcCtD
Phenylephrine—Vision blurred—Paclitaxel—lung cancer	0.000823	0.00106	CcSEcCtD
Phenylephrine—Hyperhidrosis—Gemcitabine—lung cancer	0.000823	0.00106	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000822	0.00106	CcSEcCtD
Phenylephrine—Visual impairment—Docetaxel—lung cancer	0.00082	0.00106	CcSEcCtD
Phenylephrine—Dizziness—Topotecan—lung cancer	0.000819	0.00106	CcSEcCtD
Phenylephrine—Tremor—Paclitaxel—lung cancer	0.000818	0.00106	CcSEcCtD
Phenylephrine—Vomiting—Vinblastine—lung cancer	0.000811	0.00105	CcSEcCtD
Phenylephrine—Dizziness—Erlotinib—lung cancer	0.000811	0.00105	CcSEcCtD
Phenylephrine—Agitation—Paclitaxel—lung cancer	0.000803	0.00104	CcSEcCtD
Phenylephrine—Headache—Vinblastine—lung cancer	0.000799	0.00103	CcSEcCtD
Phenylephrine—Cardiac disorder—Docetaxel—lung cancer	0.000789	0.00102	CcSEcCtD
Phenylephrine—Vomiting—Topotecan—lung cancer	0.000788	0.00102	CcSEcCtD
Phenylephrine—Paraesthesia—Irinotecan—lung cancer	0.000785	0.00101	CcSEcCtD
Phenylephrine—Syncope—Paclitaxel—lung cancer	0.000783	0.00101	CcSEcCtD
Phenylephrine—Loss of consciousness—Etoposide—lung cancer	0.000783	0.00101	CcSEcCtD
Phenylephrine—Rash—Topotecan—lung cancer	0.000781	0.00101	CcSEcCtD
Phenylephrine—Hypersensitivity—Vinorelbine—lung cancer	0.000781	0.00101	CcSEcCtD
Phenylephrine—Dermatitis—Topotecan—lung cancer	0.00078	0.00101	CcSEcCtD
Phenylephrine—Vomiting—Erlotinib—lung cancer	0.000779	0.00101	CcSEcCtD
Phenylephrine—Dyspnoea—Irinotecan—lung cancer	0.000779	0.00101	CcSEcCtD
Phenylephrine—Nervous system disorder—Cisplatin—lung cancer	0.000778	0.00101	CcSEcCtD
Phenylephrine—Headache—Topotecan—lung cancer	0.000776	0.001	CcSEcCtD
Phenylephrine—Tachycardia—Cisplatin—lung cancer	0.000774	0.001	CcSEcCtD
Phenylephrine—Rash—Erlotinib—lung cancer	0.000773	0.000999	CcSEcCtD
Phenylephrine—Dermatitis—Erlotinib—lung cancer	0.000772	0.000998	CcSEcCtD
Phenylephrine—Palpitations—Paclitaxel—lung cancer	0.000772	0.000997	CcSEcCtD
Phenylephrine—Angiopathy—Docetaxel—lung cancer	0.000772	0.000997	CcSEcCtD
Phenylephrine—Skin disorder—Cisplatin—lung cancer	0.000771	0.000996	CcSEcCtD
Phenylephrine—Hypertension—Etoposide—lung cancer	0.000769	0.000994	CcSEcCtD
Phenylephrine—Immune system disorder—Docetaxel—lung cancer	0.000768	0.000993	CcSEcCtD
Phenylephrine—Headache—Erlotinib—lung cancer	0.000768	0.000992	CcSEcCtD
Phenylephrine—Loss of consciousness—Paclitaxel—lung cancer	0.000768	0.000992	CcSEcCtD
Phenylephrine—Hyperhidrosis—Cisplatin—lung cancer	0.000767	0.000991	CcSEcCtD
Phenylephrine—Mediastinal disorder—Docetaxel—lung cancer	0.000766	0.00099	CcSEcCtD
Phenylephrine—Paraesthesia—Gemcitabine—lung cancer	0.000764	0.000988	CcSEcCtD
Phenylephrine—Arrhythmia—Docetaxel—lung cancer	0.00076	0.000982	CcSEcCtD
Phenylephrine—Dyspnoea—Gemcitabine—lung cancer	0.000759	0.000981	CcSEcCtD
Phenylephrine—Chest pain—Etoposide—lung cancer	0.000758	0.00098	CcSEcCtD
Phenylephrine—Nausea—Vinblastine—lung cancer	0.000757	0.000979	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000755	0.000975	CcSEcCtD
Phenylephrine—Hypertension—Paclitaxel—lung cancer	0.000754	0.000974	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000753	0.000973	CcSEcCtD
Phenylephrine—Pruritus—Vinorelbine—lung cancer	0.00075	0.000969	CcSEcCtD
Phenylephrine—Pain—Irinotecan—lung cancer	0.000747	0.000966	CcSEcCtD
Phenylephrine—Mental disorder—Docetaxel—lung cancer	0.000745	0.000963	CcSEcCtD
Phenylephrine—Chest pain—Paclitaxel—lung cancer	0.000744	0.000961	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000738	0.000954	CcSEcCtD
Phenylephrine—Nausea—Topotecan—lung cancer	0.000736	0.000951	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000735	0.00095	CcSEcCtD
Phenylephrine—Pain—Gemcitabine—lung cancer	0.000728	0.000941	CcSEcCtD
Phenylephrine—Nausea—Erlotinib—lung cancer	0.000728	0.000941	CcSEcCtD
Phenylephrine—Dysgeusia—Docetaxel—lung cancer	0.000725	0.000937	CcSEcCtD
Phenylephrine—Paraesthesia—Cisplatin—lung cancer	0.000713	0.000921	CcSEcCtD
Phenylephrine—Tachycardia—Etoposide—lung cancer	0.00071	0.000917	CcSEcCtD
Phenylephrine—Dyspnoea—Cisplatin—lung cancer	0.000707	0.000914	CcSEcCtD
Phenylephrine—Skin disorder—Etoposide—lung cancer	0.000706	0.000912	CcSEcCtD
Phenylephrine—Hyperhidrosis—Etoposide—lung cancer	0.000703	0.000908	CcSEcCtD
Phenylephrine—Shock—Paclitaxel—lung cancer	0.000701	0.000906	CcSEcCtD
Phenylephrine—Dizziness—Vinorelbine—lung cancer	0.000701	0.000906	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—lung cancer	0.000701	0.000905	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000701	0.000905	CcSEcCtD
Phenylephrine—Nervous system disorder—Paclitaxel—lung cancer	0.000699	0.000903	CcSEcCtD
Phenylephrine—Tachycardia—Paclitaxel—lung cancer	0.000696	0.000899	CcSEcCtD
Phenylephrine—Skin disorder—Paclitaxel—lung cancer	0.000692	0.000895	CcSEcCtD
Phenylephrine—Hyperhidrosis—Paclitaxel—lung cancer	0.000689	0.00089	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000685	0.000885	CcSEcCtD
Phenylephrine—Pain—Cisplatin—lung cancer	0.000679	0.000877	CcSEcCtD
Phenylephrine—Vomiting—Vinorelbine—lung cancer	0.000674	0.000871	CcSEcCtD
Phenylephrine—Rash—Vinorelbine—lung cancer	0.000668	0.000863	CcSEcCtD
Phenylephrine—Dermatitis—Vinorelbine—lung cancer	0.000668	0.000863	CcSEcCtD
Phenylephrine—Headache—Vinorelbine—lung cancer	0.000664	0.000858	CcSEcCtD
Phenylephrine—Syncope—Docetaxel—lung cancer	0.000664	0.000858	CcSEcCtD
Phenylephrine—Palpitations—Docetaxel—lung cancer	0.000654	0.000845	CcSEcCtD
Phenylephrine—Paraesthesia—Etoposide—lung cancer	0.000653	0.000843	CcSEcCtD
Phenylephrine—Loss of consciousness—Docetaxel—lung cancer	0.000651	0.000841	CcSEcCtD
Phenylephrine—Dyspnoea—Etoposide—lung cancer	0.000648	0.000837	CcSEcCtD
Phenylephrine—Hypersensitivity—Irinotecan—lung cancer	0.000644	0.000832	CcSEcCtD
Phenylephrine—Paraesthesia—Paclitaxel—lung cancer	0.00064	0.000827	CcSEcCtD
Phenylephrine—Hypertension—Docetaxel—lung cancer	0.000639	0.000826	CcSEcCtD
Phenylephrine—Dyspnoea—Paclitaxel—lung cancer	0.000635	0.000821	CcSEcCtD
Phenylephrine—Chest pain—Docetaxel—lung cancer	0.00063	0.000814	CcSEcCtD
Phenylephrine—Nausea—Vinorelbine—lung cancer	0.000629	0.000813	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Etoposide—lung cancer	0.000628	0.000811	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000626	0.000809	CcSEcCtD
Phenylephrine—Pain—Etoposide—lung cancer	0.000622	0.000803	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000615	0.000795	CcSEcCtD
Phenylephrine—Pain—Paclitaxel—lung cancer	0.00061	0.000788	CcSEcCtD
Phenylephrine—Pruritus—Gemcitabine—lung cancer	0.000602	0.000778	CcSEcCtD
Phenylephrine—Shock—Docetaxel—lung cancer	0.000594	0.000768	CcSEcCtD
Phenylephrine—Nervous system disorder—Docetaxel—lung cancer	0.000593	0.000766	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—lung cancer	0.000591	0.000763	CcSEcCtD
Phenylephrine—Tachycardia—Docetaxel—lung cancer	0.00059	0.000762	CcSEcCtD
Phenylephrine—Skin disorder—Docetaxel—lung cancer	0.000587	0.000758	CcSEcCtD
Phenylephrine—Hypersensitivity—Cisplatin—lung cancer	0.000585	0.000755	CcSEcCtD
Phenylephrine—Dizziness—Irinotecan—lung cancer	0.000578	0.000747	CcSEcCtD
Phenylephrine—Urticaria—Etoposide—lung cancer	0.000578	0.000746	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—lung cancer	0.000569	0.000735	CcSEcCtD
Phenylephrine—Urticaria—Paclitaxel—lung cancer	0.000566	0.000732	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—lung cancer	0.000556	0.000719	CcSEcCtD
Phenylephrine—Vomiting—Irinotecan—lung cancer	0.000556	0.000718	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—lung cancer	0.000554	0.000715	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—lung cancer	0.000552	0.000714	CcSEcCtD
Phenylephrine—Rash—Irinotecan—lung cancer	0.000551	0.000712	CcSEcCtD
Phenylephrine—Dermatitis—Irinotecan—lung cancer	0.000551	0.000711	CcSEcCtD
Phenylephrine—Headache—Irinotecan—lung cancer	0.000548	0.000707	CcSEcCtD
Phenylephrine—Paraesthesia—Docetaxel—lung cancer	0.000543	0.000701	CcSEcCtD
Phenylephrine—Vomiting—Gemcitabine—lung cancer	0.000541	0.000699	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—lung cancer	0.00054	0.000698	CcSEcCtD
Phenylephrine—Dyspnoea—Docetaxel—lung cancer	0.000539	0.000696	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—lung cancer	0.000537	0.000694	CcSEcCtD
Phenylephrine—Rash—Gemcitabine—lung cancer	0.000537	0.000694	CcSEcCtD
Phenylephrine—Dermatitis—Gemcitabine—lung cancer	0.000536	0.000693	CcSEcCtD
Phenylephrine—Hypersensitivity—Etoposide—lung cancer	0.000536	0.000692	CcSEcCtD
Phenylephrine—Headache—Gemcitabine—lung cancer	0.000533	0.000689	CcSEcCtD
Phenylephrine—Hypersensitivity—Paclitaxel—lung cancer	0.000525	0.000679	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—lung cancer	0.000523	0.000675	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000522	0.000674	CcSEcCtD
Phenylephrine—Nausea—Irinotecan—lung cancer	0.000519	0.000671	CcSEcCtD
Phenylephrine—Pain—Docetaxel—lung cancer	0.000517	0.000668	CcSEcCtD
Phenylephrine—Pruritus—Etoposide—lung cancer	0.000514	0.000665	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—lung cancer	0.000511	0.000661	CcSEcCtD
Phenylephrine—Nausea—Gemcitabine—lung cancer	0.000506	0.000653	CcSEcCtD
Phenylephrine—Vomiting—Cisplatin—lung cancer	0.000505	0.000652	CcSEcCtD
Phenylephrine—Pruritus—Paclitaxel—lung cancer	0.000504	0.000652	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—lung cancer	0.000503	0.00065	CcSEcCtD
Phenylephrine—Rash—Cisplatin—lung cancer	0.0005	0.000647	CcSEcCtD
Phenylephrine—Dermatitis—Cisplatin—lung cancer	0.0005	0.000646	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—lung cancer	0.000493	0.000636	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—lung cancer	0.000482	0.000622	CcSEcCtD
Phenylephrine—Dizziness—Etoposide—lung cancer	0.000481	0.000621	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—lung cancer	0.000479	0.000619	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—lung cancer	0.000478	0.000618	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—lung cancer	0.000474	0.000613	CcSEcCtD
Phenylephrine—Dizziness—Paclitaxel—lung cancer	0.000471	0.000609	CcSEcCtD
Phenylephrine—Nausea—Cisplatin—lung cancer	0.000471	0.000609	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—lung cancer	0.000465	0.000601	CcSEcCtD
Phenylephrine—Vomiting—Etoposide—lung cancer	0.000462	0.000597	CcSEcCtD
Phenylephrine—Rash—Etoposide—lung cancer	0.000458	0.000592	CcSEcCtD
Phenylephrine—Dermatitis—Etoposide—lung cancer	0.000458	0.000592	CcSEcCtD
Phenylephrine—Headache—Etoposide—lung cancer	0.000455	0.000588	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—lung cancer	0.000454	0.000587	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—lung cancer	0.000453	0.000586	CcSEcCtD
Phenylephrine—Vomiting—Paclitaxel—lung cancer	0.000453	0.000586	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—lung cancer	0.000452	0.000585	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000451	0.000583	CcSEcCtD
Phenylephrine—Rash—Paclitaxel—lung cancer	0.000449	0.000581	CcSEcCtD
Phenylephrine—Dermatitis—Paclitaxel—lung cancer	0.000449	0.00058	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—lung cancer	0.000449	0.00058	CcSEcCtD
Phenylephrine—Headache—Paclitaxel—lung cancer	0.000447	0.000577	CcSEcCtD
Phenylephrine—Hypersensitivity—Docetaxel—lung cancer	0.000445	0.000575	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—lung cancer	0.000435	0.000563	CcSEcCtD
Phenylephrine—Nausea—Etoposide—lung cancer	0.000432	0.000558	CcSEcCtD
Phenylephrine—Pruritus—Docetaxel—lung cancer	0.000427	0.000552	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—lung cancer	0.000427	0.000552	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—lung cancer	0.000425	0.000549	CcSEcCtD
Phenylephrine—Nausea—Paclitaxel—lung cancer	0.000423	0.000547	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—lung cancer	0.000423	0.000547	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—lung cancer	0.000421	0.000544	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—lung cancer	0.000414	0.000535	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—lung cancer	0.000408	0.000528	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—lung cancer	0.000406	0.000525	CcSEcCtD
Phenylephrine—Dizziness—Docetaxel—lung cancer	0.0004	0.000516	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—lung cancer	0.000399	0.000515	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—lung cancer	0.000393	0.000508	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—lung cancer	0.000391	0.000505	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000391	0.000505	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—lung cancer	0.000388	0.000502	CcSEcCtD
Phenylephrine—Vomiting—Docetaxel—lung cancer	0.000384	0.000496	CcSEcCtD
Phenylephrine—Rash—Docetaxel—lung cancer	0.000381	0.000492	CcSEcCtD
Phenylephrine—Dermatitis—Docetaxel—lung cancer	0.000381	0.000492	CcSEcCtD
Phenylephrine—Headache—Docetaxel—lung cancer	0.000378	0.000489	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000376	0.000486	CcSEcCtD
Phenylephrine—Pain—Methotrexate—lung cancer	0.000372	0.000481	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—lung cancer	0.000371	0.000479	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—lung cancer	0.00037	0.000478	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—lung cancer	0.000368	0.000476	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—lung cancer	0.000366	0.000473	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—lung cancer	0.000365	0.000471	CcSEcCtD
Phenylephrine—Nausea—Docetaxel—lung cancer	0.000359	0.000464	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—lung cancer	0.000346	0.000447	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—lung cancer	0.000339	0.000437	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—lung cancer	0.000336	0.000434	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000326	0.000421	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—lung cancer	0.000322	0.000417	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—lung cancer	0.000321	0.000415	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—lung cancer	0.000308	0.000398	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—lung cancer	0.0003	0.000387	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—lung cancer	0.000288	0.000372	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—lung cancer	0.000278	0.000359	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—lung cancer	0.000277	0.000358	CcSEcCtD
Phenylephrine—Rash—Methotrexate—lung cancer	0.000275	0.000355	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—lung cancer	0.000274	0.000354	CcSEcCtD
Phenylephrine—Headache—Methotrexate—lung cancer	0.000273	0.000352	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—lung cancer	0.000267	0.000345	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—lung cancer	0.000259	0.000334	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—lung cancer	0.000249	0.000322	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—lung cancer	0.00024	0.00031	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—lung cancer	0.000238	0.000307	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—lung cancer	0.000238	0.000307	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—lung cancer	0.000236	0.000305	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—lung cancer	0.000224	0.000289	CcSEcCtD
Phenylephrine—CYP1A2—Metabolism—GSTA1—lung cancer	5.34e-05	0.000236	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCL8—lung cancer	5.33e-05	0.000236	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAP2K1—lung cancer	5.32e-05	0.000235	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ERBB3—lung cancer	5.3e-05	0.000234	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CD—lung cancer	5.29e-05	0.000234	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCC3—lung cancer	5.28e-05	0.000233	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CG—lung cancer	5.25e-05	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	5.17e-05	0.000229	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKR1C1—lung cancer	5.11e-05	0.000226	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2—lung cancer	5.1e-05	0.000226	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AVP—lung cancer	5.09e-05	0.000225	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—POMC—lung cancer	5.08e-05	0.000225	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TERT—lung cancer	5.08e-05	0.000225	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CB—lung cancer	5.07e-05	0.000224	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STK11—lung cancer	5e-05	0.000221	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—POMC—lung cancer	5e-05	0.000221	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—UGT1A1—lung cancer	4.96e-05	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6R—lung cancer	4.96e-05	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGFR1—lung cancer	4.93e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1R—lung cancer	4.9e-05	0.000217	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL8—lung cancer	4.88e-05	0.000216	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CREBBP—lung cancer	4.87e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HIF1A—lung cancer	4.86e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FOXO3—lung cancer	4.82e-05	0.000213	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HES1—lung cancer	4.81e-05	0.000213	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNG11—lung cancer	4.78e-05	0.000212	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.76e-05	0.000211	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	4.73e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—RAF1—lung cancer	4.72e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	4.7e-05	0.000208	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOA1—lung cancer	4.69e-05	0.000207	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—lung cancer	4.66e-05	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KDR—lung cancer	4.65e-05	0.000206	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CD—lung cancer	4.61e-05	0.000204	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CB—lung cancer	4.61e-05	0.000204	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALDOA—lung cancer	4.56e-05	0.000202	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—lung cancer	4.55e-05	0.000201	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AVP—lung cancer	4.52e-05	0.0002	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	4.51e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL8—lung cancer	4.43e-05	0.000196	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOA3—lung cancer	4.42e-05	0.000196	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB3—lung cancer	4.4e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1R—lung cancer	4.35e-05	0.000192	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.35e-05	0.000192	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	4.33e-05	0.000192	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ADCY1—lung cancer	4.3e-05	0.00019	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCG2—lung cancer	4.3e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APC—lung cancer	4.28e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—lung cancer	4.28e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KIT—lung cancer	4.28e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—NRAS—lung cancer	4.28e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HES1—lung cancer	4.27e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—lung cancer	4.23e-05	0.000187	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGF—lung cancer	4.23e-05	0.000187	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HPGDS—lung cancer	4.22e-05	0.000187	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ENO2—lung cancer	4.22e-05	0.000187	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TERT—lung cancer	4.22e-05	0.000186	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.19e-05	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RAF1—lung cancer	4.19e-05	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—lung cancer	4.14e-05	0.000183	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.14e-05	0.000183	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK3—lung cancer	4.1e-05	0.000181	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGFR1—lung cancer	4.09e-05	0.000181	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	4.09e-05	0.000181	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTT1—lung cancer	4.09e-05	0.000181	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—POMC—lung cancer	4.07e-05	0.00018	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCLC—lung cancer	4.04e-05	0.000179	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2A6—lung cancer	4.04e-05	0.000179	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HIF1A—lung cancer	4.03e-05	0.000178	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.03e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BRAF—lung cancer	4.02e-05	0.000178	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CB—lung cancer	4.02e-05	0.000178	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—lung cancer	3.98e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6R—lung cancer	3.97e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CREBBP—lung cancer	3.97e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	3.93e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB3—lung cancer	3.91e-05	0.000173	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—lung cancer	3.9e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOA1—lung cancer	3.89e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KDR—lung cancer	3.86e-05	0.000171	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ENO1—lung cancer	3.83e-05	0.00017	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.82e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAP2K1—lung cancer	3.79e-05	0.000168	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.77e-05	0.000167	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CD—lung cancer	3.76e-05	0.000166	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—lung cancer	3.76e-05	0.000166	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TERT—lung cancer	3.74e-05	0.000166	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—lung cancer	3.73e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—lung cancer	3.68e-05	0.000163	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGFR1—lung cancer	3.64e-05	0.000161	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HIF1A—lung cancer	3.58e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—lung cancer	3.55e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APC—lung cancer	3.55e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KIT—lung cancer	3.55e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—NRAS—lung cancer	3.55e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGF—lung cancer	3.51e-05	0.000155	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—lung cancer	3.47e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOA1—lung cancer	3.46e-05	0.000153	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2E1—lung cancer	3.44e-05	0.000152	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KDR—lung cancer	3.43e-05	0.000152	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK3—lung cancer	3.4e-05	0.00015	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NQO1—lung cancer	3.4e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—lung cancer	3.38e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—POMC—lung cancer	3.38e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MDM2—lung cancer	3.37e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RAF1—lung cancer	3.36e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BRAF—lung cancer	3.34e-05	0.000148	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.33e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ERBB2—lung cancer	3.32e-05	0.000147	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—EP300—lung cancer	3.31e-05	0.000147	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.3e-05	0.000146	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6R—lung cancer	3.3e-05	0.000146	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CREBBP—lung cancer	3.29e-05	0.000146	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTOR—lung cancer	3.28e-05	0.000145	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CB—lung cancer	3.28e-05	0.000145	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—lung cancer	3.24e-05	0.000143	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KIT—lung cancer	3.16e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APC—lung cancer	3.16e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	3.16e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—NRAS—lung cancer	3.16e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—lung cancer	3.15e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	3.14e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—lung cancer	3.13e-05	0.000138	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	3.12e-05	0.000138	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGF—lung cancer	3.12e-05	0.000138	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	3.09e-05	0.000137	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—STK11—lung cancer	3.07e-05	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—lung cancer	3.06e-05	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—lung cancer	3.04e-05	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	3.02e-05	0.000134	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—lung cancer	3.02e-05	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—lung cancer	3.01e-05	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—POMC—lung cancer	3e-05	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—lung cancer	3e-05	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BRAF—lung cancer	2.97e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—lung cancer	2.94e-05	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6R—lung cancer	2.93e-05	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JUN—lung cancer	2.93e-05	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	2.93e-05	0.000129	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.88e-05	0.000127	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	2.87e-05	0.000127	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—lung cancer	2.85e-05	0.000126	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1A—lung cancer	2.84e-05	0.000126	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—lung cancer	2.84e-05	0.000125	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—lung cancer	2.83e-05	0.000125	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	2.81e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MDM2—lung cancer	2.8e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	2.79e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RAF1—lung cancer	2.79e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	2.77e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—lung cancer	2.76e-05	0.000122	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CAT—lung cancer	2.76e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB2—lung cancer	2.76e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	2.75e-05	0.000122	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.74e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTOR—lung cancer	2.72e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	2.72e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	2.72e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EP300—lung cancer	2.7e-05	0.00012	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCB1—lung cancer	2.68e-05	0.000119	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TYMS—lung cancer	2.64e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SRC—lung cancer	2.63e-05	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	2.62e-05	0.000116	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—lung cancer	2.61e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	2.6e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—lung cancer	2.56e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—lung cancer	2.53e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NRAS—lung cancer	2.53e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	2.53e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—lung cancer	2.5e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—lung cancer	2.5e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	2.49e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—lung cancer	2.49e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MDM2—lung cancer	2.48e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RAF1—lung cancer	2.48e-05	0.00011	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—lung cancer	2.47e-05	0.000109	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—lung cancer	2.45e-05	0.000108	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ERCC2—lung cancer	2.45e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	2.45e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—lung cancer	2.44e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JUN—lung cancer	2.43e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK3—lung cancer	2.42e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	2.42e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTOR—lung cancer	2.42e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—lung cancer	2.37e-05	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	2.36e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—lung cancer	2.35e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—lung cancer	2.35e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	2.32e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	2.31e-05	0.000102	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—lung cancer	2.3e-05	0.000102	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	2.29e-05	0.000101	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	2.24e-05	9.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EP300—lung cancer	2.24e-05	9.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—lung cancer	2.22e-05	9.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—lung cancer	2.22e-05	9.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—lung cancer	2.21e-05	9.77e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SRC—lung cancer	2.18e-05	9.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—lung cancer	2.18e-05	9.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—lung cancer	2.16e-05	9.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JUN—lung cancer	2.16e-05	9.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	2.12e-05	9.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA1—lung cancer	2.12e-05	9.38e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—lung cancer	2.1e-05	9.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—lung cancer	2.1e-05	9.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NRAS—lung cancer	2.1e-05	9.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	2.09e-05	9.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—lung cancer	2.09e-05	9.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	2.04e-05	9.02e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.03e-05	8.98e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	2.01e-05	8.89e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—lung cancer	2e-05	8.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	2e-05	8.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EP300—lung cancer	1.99e-05	8.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—lung cancer	1.95e-05	8.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SRC—lung cancer	1.94e-05	8.57e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.94e-05	8.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—lung cancer	1.93e-05	8.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.91e-05	8.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.89e-05	8.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.87e-05	8.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.86e-05	8.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—lung cancer	1.85e-05	8.18e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—POMC—lung cancer	1.84e-05	8.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.81e-05	7.99e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CREBBP—lung cancer	1.79e-05	7.94e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.79e-05	7.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—lung cancer	1.77e-05	7.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.74e-05	7.68e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.7e-05	7.53e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.7e-05	7.51e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—lung cancer	1.68e-05	7.43e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.66e-05	7.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.63e-05	7.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.61e-05	7.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.6e-05	7.1e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.54e-05	6.79e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.48e-05	6.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.47e-05	6.52e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—lung cancer	1.47e-05	6.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.47e-05	6.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—lung cancer	1.43e-05	6.31e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.36e-05	6.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.36e-05	6e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—lung cancer	1.31e-05	5.77e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—lung cancer	1.28e-05	5.67e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—EP300—lung cancer	1.22e-05	5.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.2e-05	5.33e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—lung cancer	9.04e-06	4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—lung cancer	7.39e-06	3.27e-05	CbGpPWpGaD
